StockTipsArenaBeta

BUY Piramal Pharma Limited — Sacchitanand Uttekar, Tradebulls Securities

BUYPiramal Pharma Limited

bySacchitanand Uttekar, Tradebulls SecuritiesHorizon: Intraday22 Sept 2026, 1:49 pm ISTvia Zee Business (Live)

Entry₹210.9Inferred
Target₹230
Total upside +9.06% (call closed)
Stop loss₹209-0.90% risk
At expiry₹21022 Sept 2026, 3:20 pm
Expired-0.43%
Follow Sacchitanand Uttekar for new callsGet alertsWatch PPLPHARMA for new buy/sell callsGet alerts

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 22 Sept 2026
2 supporting1 opposing
Supports the BUY call (2)

2 advisors have active swing BUY calls on this stock, all issued in the last 14 days

Advisor consensus · adjacent horizon·21 Sept · yesterday

Piramal Pharma earns ‘Leader’ ESG rating from independent assessor

NewsGoogle News·18 Sept · 3d ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (1)

Piramal Pharma shares fall 3% after USFDA issues 7 observations at UK facility

NewsCnbc-Tv18·15 Sept · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.